University of Lubeck   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Lubeck Germany (1964)

Organization Overview

First Clinical Trial
2002
NCT00912678
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Department of Anesthesiology, University of Luebeck | Department of Dermatology, University of Luebeck | Universitatsklinikum - Lubeck | Universitatsklinikum - Lubeck - Germany | University Hospital Lübeck | University of Lubeck, Dermatology Department | University of Lübeck, Zentrum für Integrative Psychiatrie ZiP gGmbH | University of Luebeck | University of Luebeck, Department of Neuroendocrinology | University of Luebeck - Department of Ophthalmology: Germany

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 3)

Cardiac Output, Low (Phase 3)

Glaucoma, Open-Angle (Phase 1)

Infarction (Phase 4)

Myocardial Infarction (Phase 4)

Pemphigus (Phase 2)

Psoriasis (Phase 4)

Shock (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 19
  • # of Trial APIs: 22